Condensed Consolidated Statements of Stockholders' Deficit (Parenthetical) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2024		Jun. 25, 2023		Jun. 30, 2024		Jun. 25, 2023		Mar. 31, 2024		Dec. 31, 2023		Mar. 26, 2023		Dec. 25, 2022
Stockholders' equity	$ (446,140)		$ (465,479)		$ (446,140)		$ (465,479)		$ (446,423)		$ (443,616)		$ (475,325)		$ (270,664)
Transaction costs on share repurchases							2,804
Accumulated other comprehensive loss
Stockholders' equity	(7,358)	[1]	(7,289)	[2]	(7,358)	[1]	(7,289)	[2]	$ (7,554)	[1]	$ (7,803)	[1]	$ (8,766)	[2]	$ (10,135)	[2]
Net unrealized foreign currency translation loss
Stockholders' equity	(7,784)		(7,274)		(7,784)		(7,274)
Net unrealized gain (loss) on interest rate swap agreements
Stockholders' equity	426		(15)		426		(15)
Corporate Joint Venture
Net income allocable to the redeemable noncontrolling interest for joint venture arrangements	$ 91		$ 59		$ 190		$ 105

[1] At June 30, 2024, the accumulated other comprehensive loss of $7,358 was comprised of net unrealized foreign currency translation loss of $7,784 and net unrealized gain on the interest rate swap agreements of $426.

[2] At June 25, 2023, the accumulated other comprehensive loss of $7,289 was comprised of net unrealized foreign currency translation loss of $7,274 and net unrealized loss on the interest rate swap agreements of $15.